Stock KAN KANCERA AB
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Kancera AB

Equities

KAN

SE0015658570

Delayed Nasdaq Stockholm
Other stock markets
 12:26:01 23/05/2024 BST 		5-day change 1st Jan Change
1.702 SEK -4.92% Intraday chart for Kancera AB +1.31% -62.55%
05-08 Kancera AB Announces Executive Changes CI
05-03 Kancera AB Reports Positive Results from the Clinical Phase I Study with KAND145 in Healthy Subjects CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
KANCERA AB Stock Kancera AB
 20.22M - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 115B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 24.69B -
ARGENX SE Stock argenx SE
 21.97B -
GENMAB A/S Stock Genmab A/S
 19.27B
  1. Stock Market
  2. Equities
  3. KAN Stock
  4. Charts Kancera AB
  5. Sector Chart